Skip to main content
Equibles
LCTX logo

LCTX · Lineage Cell Therapeutics, Inc.

Track LCTX — free

Use LCTX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.08 -0.02 (-1.82%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Customer concentration — top 2 customers 92% of revenue

2 customers — 92% of revenue (the year ended December 31, 2025)

“For the year ended December 31, 2025, the Company’s top two customers collectively represented 92% of the Company’s total revenue.”

One customer — 92% of revenue (the year ended December 31, 2024)

“For the year ended December 31, 2024, the Company's top single customer represented 92% of the Company’s total revenue.”
View the 10-K filed Mar 5, 2026
Market Cap
$273.14M
Shares
252.91M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Pull short interest history through the short interest API or MCP →

LCTX Latest Reported Short Interest

FINRA reported 28,331,489 LCTX shares sold short as of the August 14, 2026 settlement date, a decrease of 1,230,018 shares. Days to cover was 35.06 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

LCTX Short Interest Forecast

Equibles' model estimates 28,425,063 shares sold short for the August 31, 2026 settlement, +0.3% versus the latest reported position, with a likely range of 26,477,954 to 30,178,650 shares. This model prediction uses FINRA data through August 31, 2026; FINRA's official release is expected September 10, 2026.

Model estimate

Expected Aug 31 short interest

as of Aug 31 Low confidence 56% chance it falls
28,425,063 +0.3% vs reported
Likely range 26,477,954 to 30,178,650 The latest estimate appears in the chart below. Official release expected Sep 10. Methodology
Short Squeeze Score
64/100
Short interest 11.2% of shares — P92 Days to cover 35.1 — P97 Price vs VWAP -9.9% — P23 Short-volume trend -7.4% — P25 Short interest change -4.2% — P38 Worst FTD 0.02% of shares — P60

Positioning score 64.0 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-08-14). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-09-07 16:28 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-09-15 Scheduled
    FINRA publishes Sep 24
    		 — — — —
    2026-08-31 Scheduled
    FINRA publishes Sep 10
    		 — — — —
    2026-08-14 28,331,489 29,561,507 -1,230,018 35.06
    2026-07-31 29,561,507 29,867,928 -306,421 26.20
    2026-07-15 29,867,928 28,185,804 +1,682,124 34.65
    2026-06-30 28,185,804 25,555,170 +2,630,634 8.34
    2026-06-15 25,555,170 26,083,430 -528,260 23.03
    2026-05-29 26,083,430 25,915,824 +167,606 24.96
    2026-05-15 25,915,824 25,584,679 +331,145 16.76
    2026-04-30 25,584,679 25,292,784 +291,895 21.73
    2026-04-15 25,292,784 25,474,080 -181,296 24.68
    2026-03-31 25,474,080 25,466,565 +7,515 22.33
    2026-03-13 25,466,565 25,052,389 +414,176 18.39
    2026-02-27 25,052,389 25,194,839 -142,450 26.04
    2026-02-13 25,194,839 25,348,081 -153,242 17.96
    2026-01-30 25,348,081 25,102,567 +245,514 25.02
    2026-01-15 25,102,567 24,635,130 +467,437 23.93
    2025-12-31 24,635,130 23,708,947 +926,183 17.64
    2025-12-15 23,708,947 22,837,063 +871,884 19.89
    2025-11-28 22,837,063 22,579,627 +257,436 15.90
    2025-11-14 22,579,627 33,795,581 -11,215,954 6.82
    2025-10-31 33,795,581 31,772,044 +2,023,537 18.65
    2025-10-15 31,772,044 29,010,613 +2,761,431 17.79
    2025-09-30 29,010,613 27,748,083 +1,262,530 15.07
    2025-09-15 27,748,083 27,048,226 +699,857 21.14

    Full FINRA short interest reporting calendar

    Showing 1–23 of 23 settlements
    Key facts CIK 876343 CUSIP 53566P109 13F (30d) 79 filings 79 filers Visit website Investor relations